|
Therapeutics for Immune System Disorders Description This study surveys the market for small–molecules and biologic therapies for diseases caused by disorders of the immune system: therapies covered are either already used or will be used as medicine within the next 5 years (through 2015). Highlights In 2010, the global market for drugs for the treatment of immune disease was estimated to be approximately $72.2 billion. The market size is forecast to grow at a compound annual growth rate (CAGR) of 2.6% to reach $82.2 billion by 2015. The market size of immunomodulators in 2010 is estimated to be $62.8 billion, accounting for 86.9% of the overall market. The market for immunomodulators is expected to grow by a compound annual growth rate (CAGR) of 3.4% to reach $74.1 billion by 2015, accounting for 90.2% of the market. The demand for symptom–treating drugs is declining as advancements in immunology and life sciences help to target the underlying causes of the diseases. The market size of symptom treating diseases is expected to decline at a compound annual growth rate (CAGR) of –3.1% from $9.4 billion in 2010 to $8.1 billion in 2015. (http://www.bharatbook.com/detail.asp?id=192726&rt=Therapeutics-for-Immune-System-Disorders.html) Scope INTRODUCTION STUDY GOAL AND OBJECTIVES This in–depth study examines recent commercial developments in immune disease treatments. There has been an explosion in knowledge concerning the immune system, and tremendous advancements in disease diagnosis and therapies with novel approaches – predominantly biologic–based treatments – replacing the traditional methods where emphasis was to treat the symptoms in order to improve the quality of life of the patient rather than treating the underlying cause of a disease. Over the past decade this new approach to immune disease has resulted in a wealth of new drugs and procedures that selectively target the causes of immune disease. This report forecasts that this trend will continue and the worldwide market for drugs that treat immune diseases will grow from an estimated $72.2 billion in 2010 to $82.2 billion by 2015. These diseases represent some of the largest market opportunities for pharmaceutical and biotechnology companies since they are common and chronic and historic treatments have been largely ineffective. The study examines the current market for the treatment of immune disease and then projects the effects of new technologies upon this market. It contains detailed analysis and provides market forecasts for the period of 2010 through 2015 and profiles the major companies involved in treating immune disease. This report also analyzes various regulatory and market trends that will impact major immune disease segments during the forecast period. Challenges in the areas of technology and therapy are analyzed in detail and how these will be translated into important market trends and future business strategies are studied in depth and presented in the report. Finally, analysis of technology trends has been presented in the report, identifying how the most prevalent technologies in the market have changed over the past decade with the advent of biologics and future growth trends. For more information kindly visit : http://www.bharatbook.com/detail.asp?id=192726&rt=Therapeutics-for-Immune-System-Disorders.html Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668/+91 22 27579438 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/Sandhya3B
Related Articles -
Global, Therapeutics, Demand Forecast, Market, Market Forecast, Market Growth, Market Leaders, Market Share, Market Size, Research, Analysis,
| 
